Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

S Kirmani

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Phenomena

Drug Synergism

Concepts & Ideas

Activities & Behaviors

Drug Evaluation

Anatomy

Peritoneal Cavity

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
de las Alas M M; Christen R D; Gately D P; Weiner D E; Benbatoul K; Kirmani S; D'Agostino H R; Plaxe S C; Darrah D; McClay E F; Aebi S; Howell S B; Los G
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel.
Los G; Benbatoul K; Gately D P; Barton R; Christen R; Robbins K T; Vicario D; Kirmani S; Orloff L A; Weisman R; Howell S B
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
Aebi S; Schnider T W; Los G; Heath D D; Darrah D; Kirmani S; McClay E F; D'Agostino H; Plaxe S C; Fink D; De las Alas M M; Howell S B; Christen R D
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of S Kirmani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2000: de las Alas M M; Christen R D; Gately D P; Weiner D E; Benbatoul K; Kirmani S; D'Agostino H R; Plaxe S C; Darrah D; McClay E F; Aebi S; Howell S B; Los G
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel.
Cancer chemotherapy and pharmacology 2000;45(5):381-8.
1999: Los G; Benbatoul K; Gately D P; Barton R; Christen R; Robbins K T; Vicario D; Kirmani S; Orloff L A; Weisman R; Howell S B
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1610-8.
1999: Aebi S; Schnider T W; Los G; Heath D D; Darrah D; Kirmani S; McClay E F; D'Agostino H; Plaxe S C; Fink D; De las Alas M M; Howell S B; Christen R D
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel.
Cancer chemotherapy and pharmacology 1999;44(3):259-65.
1998: Weisman R A; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff L A; Wong W; Kirmani S; Howell S
Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1998;118(5):597-602.
1995: McClay E F; Braly P D; Kirmani S; Plaxe S C; Kim S; McClay M E; Wilgus L; Howell S B
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.
American journal of clinical oncology 1995;18(1):23-6.
1994: Plaxe S; Freddo J; Kim S; Kirmani S; McClay E; Christen R; Braly P; Howell S
Phase I trial of cisplatin in combination with glutathione.
Gynecologic oncology 1994;55(1):82-6.
1994: Kirmani S; Braly P S; McClay E F; Saltzstein S L; Plaxe S C; Kim S; Cates C; Howell S B
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer.
Gynecologic oncology 1994;54(3):338-44.
1994: McClay E F; Braly P D; Kirmani S; Plaxe S C; McClay M E; Wilgus L; Kim S; Howell S B
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies.
Cancer 1994;74(2):664-9.
1993: Christen R D; McClay E F; Plaxe S C; Yen S S; Kim S; Kirmani S; Wilgus L L; Heath D D; Shalinsky D R; Freddo J L
Phase I/pharmacokinetic study of high-dose progesterone and doxorubicin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2417-26.
1993: McClay E F; Goel R; Andrews P; Gorelick S; Kirmani S; Kim S; Braly P; Plaxe S; Hoff S; Alcaraz J
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
British journal of cancer 1993;68(4):783-8.
1993: Plaxe S C; Braly P S; Freddo J L; McClay E; Christen R D; Kirmani S; Kim S; Heath D; Howell S B
Phase I and pharmacokinetic study of intraperitoneal ormaplatin.
Gynecologic oncology 1993;51(1):72-7.
1993: Bonetti A; Howell S B; McClay E; Kirmani S; Goel R; Plaxe S; Braly P; Kim S
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensity.
Gynecologic oncology 1993;49(3):318-24.
1993: Plaxe S C; Braly P S; Freddo J L; McClay E; Kirmani S; Howell S B
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):651-4.
1993: Kim S; Howell S B; McClay E; Kirmani S; Goel R; Plaxe S; Braly P; Bonetti A
Dose intensification of cisplatin chemotherapy through biweekly administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):221-7.
1992: Goel R; McClay E F; Kirmani S; Kim S; Braly P F; Plaxe S C; Alcaraz J; Andrews P A; Reichman B; Markman M
Pharmacokinetic study of intraperitoneal streptozotocin.
Clinical and investigative medicine. Médecine clinique et experimentale 1992;15(5):420-6.
1991: Isonishi S; Kirmani S; Kim S; Plaxe S C; Braly P S; McClay E F; Howell S B
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamole.
Journal of the National Cancer Institute 1991;83(9):621-6.
1991: Kirmani S; Lucas W E; Kim S; Goel R; McVey L; Morris J; Howell S B
A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):649-57.
1991: McDonald B R; Kirmani S; Vasquez M; Mehta R L
Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature.
The American journal of medicine 1991;90(3):386-91.
1991: Howell S B; Kirmani S; McClay E F; Kim S; Braly P; Plaxe S
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
Seminars in oncology 1991;18(1 Suppl 3):5-10.
1990: Kirmani S; McVey L; Loo D; Howell S B
A phase I clinical trial of intraperitoneal thiotepa for refractory ovarian cancer.
Gynecologic oncology 1990;36(3):331-4.
1990: Howell S B; Kirmani S; Lucas W E; Zimm S; Goel R; Kim S; Horton M C; McVey L; Morris J; Weiss R J
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):137-45.
1990: Goel R; Andrews P A; Pfeifle C E; Abramson I S; Kirmani S; Howell S B
Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.
European journal of cancer (Oxford, England : 1990) 1990;26(1):21-7.
1990: Kirmani S; Zimm S; Cleary S M; Mowry J; Howell S B
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
Cancer chemotherapy and pharmacology 1990;25(6):454-8.
1989: Goel R; Cleary S M; Horton C; Kirmani S; Abramson I; Kelly C; Howell S B
Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin.
Journal of the National Cancer Institute 1989;81(20):1552-60.
1989: Goel R; Cleary S M; Horton C; Balis F M; Zimm S; Kirmani S; Howell S B
Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(2):262-9.
1989: Howell S B; Kirmani S; Goel R
Novel approaches to intraperitoneal drug delivery.
Acta medica Austriaca 1989;16(3-4):61-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

S Kirmani

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Phenomena

Concepts & Ideas

Activities & Behaviors

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of S Kirmani (preview)

All Publications